PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease (POINT-NOCAD)
A Single Center Study of Perivascular Coronary Inflammation in Patients With Myocardial Ischemia or Infarction With Non-Obstructive Coronary Arteries
Sponsor: NYU Langone Health
Terminated
Study was terminated due to funding expiration.
A observational or N/A phase clinical study on Non-Obstructive Coronary Atherosclerosis, this trial is terminated or withdrawn. The trial is conducted by NYU Langone Health and has accumulated 8 data snapshots since 2021. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
May 2025 — Present [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
Oct 2024 — May 2025 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Jul 2023 — Jun 2024 [monthly]
Recruiting
Phase: NA → None
-
Sep 2022 — Jul 2023 [monthly]
Recruiting NA
-
Oct 2021 — Sep 2022 [monthly]
Recruiting NA
First recorded
Jul 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- NYU Langone Health
For direct contact, visit the study record on ClinicalTrials.gov .